Table 3.
Microbial alterations in faeces of study patients from the FECSU cohort.
| Total | Control | Dysplasia | Cancer | P-value | |
|---|---|---|---|---|---|
| n = 229 | n = 63 | n = 128 | n = 38 | ||
| P. micra (%) | |||||
| Low | 177 (77.3) | 55 (87.3) | 107 (83.6) | 15 (39.5) | < 0.001 |
| High | 52 (22.7) | 8 (12.7) | 21 (16.4) | 23 (60.5) | |
| F. nucleatum (%) | |||||
| Low | 166 (76.1) | 48 (81.4) | 104 (84.6) | 14 (38.9) | < 0.001 |
| High | 52 (23.9) | 11 (18.6) | 19 (15.4) | 22 (61.1) | |
| clbA + bacteria (%) | |||||
| Low | 154 (69.1) | 47 (77.0) | 91 (72.8) | 16 (43.2) | 0.001 |
| High | 69 (30.9) | 14 (23.0) | 34 (27.2) | 21 (56.8) | |
χ2 tests were used to compare categorical variables.